ORPHAZYME A/S
CVR number: 32266355
Lyskær 8 A, 2730 Herlev
tel: 28126609
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | |||||
| Costs of management | -50 541.00 | - 247 250.00 | -83 472.00 | ||
| Other operating expenses | - 285 413.00 | - 361 284.00 | -1.00 | -41 241.00 | -27 041.00 |
| EBIT | - 335 954.00 | - 608 534.00 | -83 473.00 | -41 241.00 | -27 041.00 |
| Other financial income | 316.00 | 2 444.00 | 37.00 | 185.00 | 993.00 |
| Other financial expenses | -7 359.00 | -29 071.00 | |||
| Pre-tax profit | - 342 997.00 | - 635 161.00 | -83 436.00 | -41 056.00 | -26 048.00 |
| Income taxes | 5 500.00 | 1 915.00 | 4 941.00 | 2 750.00 | |
| Profit/loss from discontinued operations | - 548 044.00 | 73 378.00 | |||
| Net earnings | - 337 497.00 | - 633 246.00 | - 626 539.00 | 35 072.00 | -26 048.00 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 12 454.00 | 2 152.00 | |||
| Intangible assets total | 12 454.00 | 2 152.00 | |||
| Other tangible assets | 4 687.00 | 2 985.00 | |||
| Tangible assets total | 4 687.00 | 2 985.00 | |||
| Other non-current investments | 16 873.00 | 6 398.00 | |||
| Investments total | 16 873.00 | 6 398.00 | |||
| Deferred tax assets | 4 815.00 | 2 750.00 | |||
| Long term receivables total | 4 815.00 | 2 750.00 | |||
| Inventories total | |||||
| Current trade debtors | 29 268.00 | 4 103.00 | |||
| Current other receivables | - 123 588.00 | 51 235.00 | 20 192.00 | 8 305.00 | 1 099.00 |
| Current deferred tax assets | 5 500.00 | 7 229.00 | 5 500.00 | ||
| Short term receivables total | - 123 588.00 | 56 735.00 | 56 689.00 | 17 908.00 | 1 099.00 |
| Current other shares and ownership | 6 944.00 | ||||
| Cash and bank deposits | 123 588.00 | 726 929.00 | 102 255.00 | 38 918.00 | 11 269.00 |
| Cash and cash equivalents | 123 588.00 | 726 929.00 | 102 255.00 | 38 918.00 | 18 213.00 |
| Balance sheet total (assets) | 822 493.00 | 173 229.00 | 56 826.00 | 19 312.00 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 34 698.00 | 34 952.00 | 35 312.00 | 12 283.00 | |
| Share premium account | 2 082 254.00 | 2 082 486.00 | 2 087 437.00 | ||
| Other reserves | 52 969.00 | 6 494.00 | 2 899.00 | - 303.00 | |
| Retained earnings | 337 497.00 | - 869 675.00 | -1 484 459.00 | -2 116 544.00 | 28 007.00 |
| Profit of the financial year | - 337 497.00 | - 633 246.00 | - 626 539.00 | 35 072.00 | -26 048.00 |
| Shareholders equity total | 52 969.00 | 620 525.00 | 9 339.00 | 40 974.00 | 14 242.00 |
| Non-current loans from credit institutions | 23 830.00 | 2 482.00 | |||
| Non-current leasing loans | 9 877.00 | 3 925.00 | |||
| Non-current other liabilities | 1 634.00 | 28 391.00 | 98.00 | ||
| Non-current liabilities total | 35 341.00 | 34 798.00 | 98.00 | ||
| Current loans from credit institutions | 33 349.00 | 30 983.00 | |||
| Current leasing loans | 3 657.00 | 2 578.00 | |||
| Current trade creditors | 9 206.00 | 5 070.00 | |||
| Short-term deferred tax liabilities | 4 159.00 | 584.00 | |||
| Other non-interest bearing current liabilities | -52 969.00 | 125 462.00 | 94 947.00 | 6 547.00 | |
| Current liabilities total | -52 969.00 | 166 627.00 | 129 092.00 | 15 753.00 | 5 070.00 |
| Balance sheet total (liabilities) | 822 493.00 | 173 229.00 | 56 825.00 | 19 312.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.